These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 1906096)

  • 1. Formulary policy for cholesterol reduction.
    J Gen Intern Med; 1991; 6(3):266-7. PubMed ID: 1906096
    [No Abstract]   [Full Text] [Related]  

  • 2. Lowering the cost of lowering the cholesterol: a formulary policy for lovastatin.
    Lederle FA; Rogers EM
    J Gen Intern Med; 1990; 5(6):459-63. PubMed ID: 2266425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effective treatment of hypercholesterolemia.
    Parsons WB
    Arch Intern Med; 1998 Aug 10-24; 158(15):1723-4. PubMed ID: 9701113
    [No Abstract]   [Full Text] [Related]  

  • 4. Reducing high blood cholesterol level with drugs. Cost-effectiveness of pharmacologic management.
    Schulman KA; Kinosian B; Jacobson TA; Glick H; Willian MK; Koffer H; Eisenberg JM
    JAMA; 1990 Dec; 264(23):3025-33. PubMed ID: 2123013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative effects of lovastatin and niacin in primary hypercholesterolemia. A prospective trial.
    Illingworth DR; Stein EA; Mitchel YB; Dujovne CA; Frost PH; Knopp RH; Tun P; Zupkis RV; Greguski RA
    Arch Intern Med; 1994 Jul; 154(14):1586-95. PubMed ID: 8031206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination drug therapy for hypercholesterolemia. The trade-off between cost and simplicity.
    Heudebert GR; Van Ruiswyk J; Hiatt J; Schectman G
    Arch Intern Med; 1993 Aug; 153(15):1828-37. PubMed ID: 8333817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lovastatin alone and in combination for treatment of primary hypercholesterolemia.
    Stein EA; Lamkin GE; Bewley DZ
    Prog Clin Biol Res; 1988; 255():281-93. PubMed ID: 3340642
    [No Abstract]   [Full Text] [Related]  

  • 8. Cost-effectiveness of rosuvastatin compared with other statins from a managed care perspective.
    Benner JS; Smith TW; Klingman D; Tierce JC; Mullins CD; Pethick N; O'Donnell JC
    Value Health; 2005; 8(6):618-28. PubMed ID: 16283862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controlling cholesterol with drugs.
    Stoy DB
    Am J Nurs; 1989 Dec; 89(12):1628-31. PubMed ID: 2589420
    [No Abstract]   [Full Text] [Related]  

  • 10. Lack of effect of lovastatin therapy on the parameters of whole-body cholesterol metabolism.
    Goldberg IJ; Holleran S; Ramakrishnan R; Adams M; Palmer RH; Dell RB; Goodman DS
    J Clin Invest; 1990 Sep; 86(3):801-8. PubMed ID: 2394831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An interactive computer system for formulary management using cost-effectiveness analysis.
    Lee JH; Glick HA; Kinosian B; Schulman KA
    MD Comput; 1995; 12(1):59-65. PubMed ID: 7854081
    [No Abstract]   [Full Text] [Related]  

  • 12. Nicotinic acid as a lipoprotein-altering agent. Therapy directed by the primary physician.
    Probstfield JL; Hunninghake DB
    Arch Intern Med; 1994 Jul; 154(14):1557-9. PubMed ID: 8031204
    [No Abstract]   [Full Text] [Related]  

  • 13. Current and new therapy for hypercholesterolemia.
    Hunninghake DB
    J Am Osteopath Assoc; 1988 Jul; 88(7):865-9. PubMed ID: 3215796
    [No Abstract]   [Full Text] [Related]  

  • 14. A population-based treat-to-target pharmacoeconomic analysis of HMG-CoA reductase inhibitors in hypercholesterolemia.
    Hilleman DE; Phillips JO; Mohiuddin SM; Ryschon KL; Pedersen CA
    Clin Ther; 1999 Mar; 21(3):536-62. PubMed ID: 10321422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Niacin-ER and lovastatin treatment of hypercholesterolemia and mixed dyslipidemia.
    Yim BT; Chong PH
    Ann Pharmacother; 2003 Jan; 37(1):106-15. PubMed ID: 12503944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formularies tighten and physicians adapt.
    Lawrence J
    Manag Care; 1998 Mar; 7(3):23-6, 29-30. PubMed ID: 10177957
    [No Abstract]   [Full Text] [Related]  

  • 17. The role of pharmacy benefit managers in formulary design: service providers or fiduciaries?
    Abrams LW
    J Manag Care Pharm; 2004; 10(4):359-60. PubMed ID: 15298536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High technology drugs for cancer: the decision process for adding to a formulary.
    Glennie JL; Woloschuk DM; Hall KW
    Pharmacoeconomics; 1993 Dec; 4(6):405-13. PubMed ID: 10146908
    [No Abstract]   [Full Text] [Related]  

  • 19. Drug wars.
    BeSaw L
    Tex Med; 1997 Nov; 93(11):34-9. PubMed ID: 9369086
    [No Abstract]   [Full Text] [Related]  

  • 20. Cholesterol management in patients with heart disease. Emphasizing secondary prevention to increase longevity.
    Grundy SM
    Postgrad Med; 1997 Aug; 102(2):81-4, 87-90. PubMed ID: 9270702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.